4.6 Article

Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments

Julia Dulsat et al.

Summary: In order for a new molecular entity (NME) to become a drug, it is important to predict its pharmacokinetic properties, including toxicity (ADMET), during the early stages of development. This paper analyzes 18 free online tools capable of predicting ADMET properties, considering their advantages, disadvantages, model-based calculations, and accuracy using experimental data for FDA-approved tyrosine kinase inhibitors (TKIs) as a case study.

MOLECULES (2023)

Review Biochemistry & Molecular Biology

Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs

Georgia Dorahy et al.

Summary: Central nervous system (CNS) disorders lack sufficient treatment options, leading to a demand for new therapies. Computer-aided drug design (CADD) techniques offer a solution by minimizing time and cost burdens associated with drug research and development. CADD encompasses ligand-based and structure-based methods, including deep learning techniques, which have shown promise in CNS drug discovery. This review investigates various CADD techniques and their applications in CNS drug discovery from 2018 to November 2022.

MOLECULES (2023)

Review Biotechnology & Applied Microbiology

Shedding light on structure, function and regulation of human sirtuins: a comprehensive review

Abhishek Sharma et al.

Summary: Sirtuins are a group of proteins that play important roles in various metabolic regulations. They possess different activities and are located in different parts of the cell. There are seven types of human sirtuins identified so far and they are involved in regulating lipid and glucose homeostasis, DNA repair, inflammation, and aging. Sirtuins are also overexpressed in certain cancers and can be potential targets for disease prevention and treatment.

3 BIOTECH (2023)

Review Biochemistry & Molecular Biology

Computational Approaches to the Rational Design of Tubulin-Targeting Agents

Helena Perez-Pena et al.

Summary: Microtubules are essential in cellular processes and have potential as targets for cancer and neurodegeneration research. However, current tubulin binders have limitations, making the discovery of safer and more efficient agents necessary. Computer-aided design techniques and accessible tubulin-ligand structures can aid in the selection and design of new tubulin-targeting agents.

BIOMOLECULES (2023)

Review Pharmacology & Pharmacy

Heat shock proteins and cancer: The FoxM1 connection

Zahra Alimardan et al.

Summary: Heat shock proteins (Hsps), including Hsp70, Hsp90, and small Hsps, and the transcription factor FoxM1, have important roles in carcinogenesis. Hsp70 functions in cancer initiation and protein folding, and is overexpressed in human cancers. It also interacts with cochaperones and regulates the FoxM1 signaling pathway. FoxM1 is overexpressed in most human cancers and is involved in various cancer-related processes. This review covers the structure, function, and inhibitors of Hsp70, Hsp90, and FoxM1.

BIOCHEMICAL PHARMACOLOGY (2023)

Article Chemistry, Medicinal

Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti-inflammatory/Antioxidant Agents

Elena Cichero et al.

Summary: In the past few years, we have developed a large library of new selective phosphodiesterase 4D (PDE4D) inhibitors. These inhibitors retain the catechol portion of the well-known PDE4 inhibitor Rolipram, with different substitutions in place of the lactam group. Through molecular docking studies, we designed and synthesized new compounds that showed potential PDE4 inhibitory activity, especially with the enzyme's flat aromatic residues. In vitro assays confirmed their antioxidant/anti-inflammatory activity, similar to other known PDE4 inhibitors.

CHEMMEDCHEM (2023)

Article Biochemistry & Molecular Biology

Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors

Naomi Scarano et al.

Summary: This article focuses on the selective inhibitors of SIRT2 enzyme. By using SBVS method, a potential molecular scaffold for designing new SIRT2 inhibitors was identified. Experimental results showed that this molecular scaffold exhibited strong SIRT2 inhibitory activity, validating the effectiveness of the research strategy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?

Nayla Mouawad et al.

Summary: The ongoing search for molecules involved in apoptosis resistance and pathogenesis of onco-hematological malignancies has identified Heat Shock Protein of 70kDa (HSP70) as a potential therapeutic target. HSP70, a highly cytoprotective protein, is induced in response to various insults and is associated with poor prognosis and therapy resistance in onco-hematological diseases. This review provides an overview of HSP70's potential as a therapeutic target and explores its partners and inhibitors.

BIOMOLECULES (2023)

Article Microbiology

GC-MS Analysis, Antibacterial, and Anticancer Activities of Hibiscus sabdariffa L. Methanolic Extract: In Vitro and In Silico Studies

Amira E. E. Sehim et al.

Summary: The emergence of multi-drug resistant bacteria poses a serious threat to human health. This study investigated the antibacterial efficacy of various extracts from three medicinal plants against pathogenic bacteria. The methanol extract of Hibiscus sabdariffa showed the highest effectiveness against all tested bacteria, including multidrug-resistant strains. Furthermore, a combination of H. sabdariffa extract and piperacillin/tazobactam showed promising results.

MICROORGANISMS (2023)

Review Biochemistry & Molecular Biology

A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research

Mukesh Nandave et al.

Summary: Sirtuins are NAD+-dependent enzymes that play a crucial role in the pathogenesis and treatment of various disorders. They are protein deacetylases expressed widely in the body and are involved in DNA repair, cellular metabolism, mitochondrial function, and inflammation. Deletion of SIRT1 protein in organs like the brain, heart, liver, and pancreas can lead to inflammation and oxidative stress, which are closely associated with chronic diseases. Modulating SIRT1 gene expression may help prevent the progression of these chronic diseases.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

Article Biochemistry & Molecular Biology

Thiadiazine-thiones as inhibitors of leishmania pteridine reductase (PTR1) target: investigations and in silico approach

Amneh Shtaiwi

Summary: This study identified potential compounds for Leishmania using various methods, including physicochemical investigations, structure-based virtual screening, ADMET analysis, molecular dynamics simulation, and MM-PBSA. After evaluating 30,926 natural products, four compounds showed good binding interaction with the active site of leishmania pteridine reductase enzyme PTR1. These compounds followed Lipinski's rule of five and can be considered as good oral candidates.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Chemistry, Multidisciplinary

Antiproliferative Activities and SwissADME Predictions of Physicochemical Properties of Carbonyl Group-Modified Rotenone Analogues

Rajelle D. D. Hernandez et al.

Summary: In this study, a library of carbonyl group-modified rotenone derivatives were synthesized and evaluated for their antiproliferative activities against cancer cells. Promising compounds were found, including oxime and alcohol rotenone derivatives that exhibited antiproliferative activities against all 3 cancer cell lines. The findings highlight the potential of these rotenone derivatives as promising chemotherapeutic candidates.

CHEMISTRYOPEN (2023)

Article Environmental Sciences

An In Silico Analysis of Synthetic and Natural Compounds as Inhibitors of Nitrous Oxide Reductase (N2OR) and Nitrite Reductase (NIR)

Radhakrishnan Narayanaswamy et al.

Summary: In this study, molecular docking experiments were conducted to identify inhibitors of N2OR and NIR. Nine compounds were found to comply with the TICE rule and showed no toxicity to honey bees. These findings suggest the potential future applications of these compounds as significant nitrification inhibitors.

TOXICS (2023)

Review Chemistry, Medicinal

Sirtuin modulators: past, present, and future perspectives

Francesco Fiorentino et al.

Summary: Sirtuins, NAD(+)-dependent protein enzymes, are found in both prokaryotes and eukaryotes, playing crucial roles in various biological processes. They have been recognized for their potential therapeutic applications in treating diseases.

FUTURE MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays

Alice Parodi et al.

Summary: This study focuses on the design and testing of new small molecules as CFTR correctors for the treatment of cystic fibrosis. Through molecular modeling and experimental validation, three molecules were identified to have a good efficacy in rescuing the defect of F508del-CFTR. This study provides valuable information for the development of targeted therapies for cystic fibrosis.

PHARMACEUTICALS (2022)

Article Plant Sciences

Anticancer and Antioxidant Activities of the Root Extract of the Carnivorous Pitcher Plant Sarracenia purpurea

Yen-Hua Huang et al.

Summary: In this study, the antioxidant and anticancer properties of Sarracenia purpurea extracts from different parts of the plant were investigated. The root extract obtained using acetone showed the highest anticancer activities and antioxidant capacity. The combination of the root extract with the anticancer drug 5-fluorouracil exhibited efficient inhibition of breast cancer cells. The root extract also showed potential as an inhibitor of human dihydroorotase, an enzyme involved in cancer chemotherapy.

PLANTS-BASEL (2022)

Review Biochemistry & Molecular Biology

Virtual Screening in the Identification of Sirtuins' Activity Modulators

Elena Abbotto et al.

Summary: This review discusses the pharmacological approaches based on sirtuins' modulators, highlighting the therapeutic potential of targeting specific sirtuin isoforms in cancer, neurodegenerative disorders and type 2 diabetes. Extensive research has been conducted on SIRT-1 and -2 modulators, while compounds targeting other sirtuins have been less studied.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

The sirtuin family in health and disease

Qi-Jun Wu et al.

Summary: Sirtuins, a critical protein family involved in regulating various biological processes, have shown potential therapeutic value in treating diseases. This review focuses on the history, structure, molecular mechanisms, and biological functions of the SIRT protein family, as well as summarizes the related clinical studies.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Chemistry, Medicinal

Synthesis and Structure-activity Relationship of Aminoarylthiazole Derivatives as Potential Potentiators of the Chloride Transport Defect in Cystic Fibrosis

Nara Liessi et al.

Summary: Cystic fibrosis is a common genetic disorder caused by mutations in the CFTR protein. Some aminoarylthiazoles have been identified as correctors and potentiators for CFTR, with compounds 2 and 13 showing promise for future development as potentiators for chloride transport defects in cystic fibrosis.

MEDICINAL CHEMISTRY (2021)

Review Pharmacology & Pharmacy

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases

Ramu Manjula et al.

Summary: Sirtuins, a group of NAD(+) dependent histone deacetylases, play a crucial role in neuroprotection and cellular senescence. They regulate crucial proteins and can be targeted for therapeutic purposes in metabolic disorders. Their modulation shows promise in treating neurodegenerative diseases associated with aging and protein homeostasis.

FRONTIERS IN PHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Sirtuin Modulators in Cellular and Animal Models of Human Diseases

Jun Young Hong et al.

Summary: Sirtuins utilize NAD(+) to regulate cellular functions, are implicated in various human diseases, and thus the development of sirtuin modulators is of significant importance.

FRONTIERS IN PHARMACOLOGY (2021)

Review Physiology

Sirtuins at the Service of Healthy Longevity

Mateusz Watroba et al.

Summary: The translated text introduces the role of sirtuins in combating organismal aging by regulating intracellular signaling pathways, reducing reactive oxygen species production, and cellular stress response to delay aging. It also emphasizes the importance of caloric restriction in this process and suggests new therapeutic possibilities.

FRONTIERS IN PHYSIOLOGY (2021)

Article Chemistry, Medicinal

Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV Agents

Elena Cichero et al.

Summary: Targeting the fusion (F) protein is a recognized strategy for developing anti-RSV agents, with benzimidazole-containing derivatives showing promise in clinical trials. Computational studies based on X-ray crystallographic data of RSV F protein revealed key contacts supporting the benzimidazole F protein inhibitor ability. The results emphasized the importance of hydrophobic interactions, pi-pi stacking, and H-bonding in the binding ability of benzimidazole F protein inhibitors.

PHARMACEUTICALS (2021)

Article Chemistry, Medicinal

Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR Modulators

Roberto Sabbadini et al.

Summary: Cystic fibrosis is caused by mutations related to the CFTR gene, with the most common one being F508del. Recent studies have encouraged the use of triple combination therapy for treating cystic fibrosis, while combinations of molecules interacting with other proteins involved in CFTR channel function are also considered a promising approach.

PHARMACEUTICALS (2021)

Article Biochemistry & Molecular Biology

PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA

Melissa F. Adasme et al.

Summary: With the growth of protein structure data, the analysis of molecular interactions between ligands and their target molecules becomes increasingly important. PLIP, a tool for protein-ligand interaction profiling, has been successful in detecting and visualizing these interactions, with applications ranging from characterizing docking experiments to evaluating novel ligand-protein complexes. Additionally, PLIP has been extended to encompass interactions with DNA and RNA, demonstrating its utility in scenarios such as cancer drug targeting DNA and RNA-protein complexes associated with neurological diseases.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemistry & Molecular Biology

Unexpected small molecules as novel SIRT2 suicide inhibitors

Xiaoxue Chen et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Review Chemistry, Medicinal

Sirtuin modulators: where are we now? A review of patents from 2015 to 2019

Nicola Mautone et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2020)

Article Biochemistry & Molecular Biology

Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists

Gabriele Murineddu et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket

Sandeep Sundriyal et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study

Matthias Schiedel et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics

Giovanna Sociali et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Selectivity hot-spots of sirtuin catalytic cores

Marco Daniele Parenti et al.

MOLECULAR BIOSYSTEMS (2015)

Article Biochemistry & Molecular Biology

PLIP: fully automated protein-ligand interaction profiler

Sebastian Salentin et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Multidisciplinary Sciences

Selective Sirt2 inhibition by ligand-induced rearrangement of the active site

Tobias Rumpf et al.

NATURE COMMUNICATIONS (2015)

Article Biochemical Research Methods

Shaping the interaction landscape of bioactive molecules

David Gfeller et al.

BIOINFORMATICS (2013)

Review Pharmacology & Pharmacy

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher A. Lipinski et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Article Multidisciplinary Sciences

A Molecular Mechanism for Direct Sirtuin Activation by Resveratrol

Melanie Gertz et al.

PLOS ONE (2012)

Article Chemistry, Medicinal

Structure-Based Design of Pseudopeptidic Inhibitors for SIRT1 and SIRT-2

Tero Huhtiniemi et al.

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes

Lei Jin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Multidisciplinary Sciences

Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease

Tiago Fleming Outeiro et al.

SCIENCE (2007)

Article Chemistry, Medicinal

Molecular properties that influence the oral bioavailability of drug candidates

DF Veber et al.

JOURNAL OF MEDICINAL CHEMISTRY (2002)

Article Biochemical Research Methods

The Protein Data Bank

HM Berman et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)

Article Biochemistry & Molecular Biology

The Protein Data Bank

HM Berman et al.

NUCLEIC ACIDS RESEARCH (2000)